DNA Clutch Probes for Circulating Tumor DNA Analysis
Authors:
- Jagotamoy DasJDJagotamoy Das
- Ivaylo IvanovIIIvaylo Ivanov
- Edward H. SargentESEdward H. Sargent
- 19 August 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 138 (34) , 11009-11016
Abstract
Progress towards the development of minimally-invasive liquid biopsies of disease is being bolstered by breakthroughs in the analysis of circulating tumor DNA (ctDNA) - DNA released from cancer cells into the bloodstream. However, robust, sensitive, and specific methods of detecting this emerging analyte are lacking. ctDNA analysis has unique challenges, since it is imperative to distinguish circulating DNA from normal cells vs. mutation-bearing sequences originating from tumors. Here we report the electrochemical detection of mutated ctDNA in samples collected from can-cer patients. By developing a strategy relying on the use of DNA clutch probes (DCP) that render specific sequences of ctDNA accessible, we were able to readout the presence of mutated ctDNA. DCPs prevent re-association of denatured DNA strands: they make one of the two strands of a dsDNA accessible for hybridization to a probe, and also deactivate other closely-related sequences in solution. DCPs ensure thereby that only mutated sequences associate with chip-based sensors detecting hybridization events. The assay exhibits excellent sensitivity and specificity in the detection of mutated ctDNA: it detects 1 fg/μL of a target mutation in the presence of 100 pg/μL of wild-type DNA, corresponding to detecting mutations at a level of 0.01% relative to wild type. This approach allows accurate analysis of samples collected from lung cancer and melanoma patients. This work represents the first detection of ctDNA without enzymatic amplification.Keywords
Funding Information
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Canadian Cancer Society Research Institute (702414)
- Ontario Research Fund
This publication has 52 references indexed in Scilit:
- Characterization of denaturation and renaturation of DNA for DNA hybridizationEnvironmental Health and Toxicology, 2014
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverageNature Medicine, 2014
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human MalignanciesScience Translational Medicine, 2014
- Tumour heterogeneity in the clinicNature, 2013
- Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in NeuroblastomaClinical Cancer Research, 2012
- Cell-free nucleic acids as biomarkers in cancer patientsNature Reviews Cancer, 2011
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literatureClinica Chimica Acta, 2010
- Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured CellsCancer Research, 2010
- Deoxyribozymes: Selection Design and Serendipity in the Development of DNA CatalystsAccounts of Chemical Research, 2009
- Denaturation, renaturation, and loss of DNA during in situ hybridization proceduresCytometry, 1986